江苏硕世生物科技股份有限公司 关于公司董事、副总经理逝世的公告

Core Points - The company announced the unfortunate passing of its director and vice president, Liu Zhonghua, due to sudden illness on September 12, 2025, expressing deep condolences and respect for his contributions [1][2] - Liu Zhonghua held 2,152,512 shares of the company, representing 2.57% of the total share capital, and the company will follow legal procedures regarding his shares [2] - Following his death, the board of directors will reduce from 9 to 8 members, which does not affect the normal operation but is below the number stipulated in the company's articles of association, prompting a need for a board member replacement [2]